Table 4.
Power (%) to detect prevalence ratios of macrolide and β-lactamase resistance in 200 Escherichia coli and 200 Streptococcus pneumoniae isolates per treatment group
| Resistance prevalence (%) in placebo group | ||||||||
| Resistance prevalence (%) in azithromycin group | 10 | 20 | 30 | 40 | 50 | 60 | 70 | |
| 10 | ||||||||
| 20 | 80 | |||||||
| 30 | >99 | 64 | ||||||
| 40 | >99 | 99 | 55 | |||||
| 50 | >99 | >99 | 98 | 48 | ||||
| 60 | >99 | >99 | >99 | >99 | 52 | |||
| 70 | >99 | >99 | >99 | >99 | 98 | 55 | ||
| 80 | >99 | >99 | >99 | >99 | >99 | 99 | 64 | |